Literature DB >> 17712988

The four most common pediatric immunodeficiencies.

Richard E Stiehm1.   

Abstract

Other than the physiologic hypogammaglobulinemia of infancy, 80% of the confirmed immunodeficiencies consist of four syndromes: transient hypogammaglobulinemia of infancy (THI), IgG subclass deficiency, partial antibody deficiency with impaired polysaccharide responsiveness (IPR), and selective IgA deficiency IgAD. None are life threatening, all can be readily managed, and many recover spontaneously. An exact incidence of these disorders is not known. A summary of immunodeficiency registries in four countries listed IgAD in 27.5% of the patients, IgG subclass deficiency in 4.8%, and THI in 2.3%. The 1999 US survey of primary immunodeficiencies conducted by the Immune Deficiency Foundation found that 17.5% of these patients had IgAD and 24% had IgG subclass deficiency, while THI and IPR were not listed. The Jeffrey Modell Foundation (2005) survey of their global centers in 2004 reported IgAD in 15.5%, subclass deficiencies in 8%, and THI in 2% of their patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712988     DOI: 10.1007/978-0-387-72005-0_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

2.  Development, manufacturing and characterization of a highly purified, liquid immunoglobulin g preparation from human plasma.

Authors:  Inga A Laursen; Lene Blou; John S Sullivan; Peter Bang; Flemming Balstrup; Gunnar Houen
Journal:  Transfus Med Hemother       Date:  2014-04-14       Impact factor: 3.747

3.  Errors in data interpretation from genetic variation of human analytes.

Authors:  Heather L Howie; Meghan Delaney; Xiaohong Wang; Lay See Er; Linda Kapp; Jenna N Lebedev; James C Zimring
Journal:  JCI Insight       Date:  2017-07-06

4.  Recurrent enterovirus encephalitis: chance or something else?

Authors:  Frankie Wai Tsoi Cheng; Paul K S Chan; Wendy C S Ho; Felix Y W Wong; T F Leung
Journal:  BMJ Case Rep       Date:  2009-06-03

Review 5.  Should newborns be screened for immunodeficiency?: lessons learned from infants with recurrent otitis media.

Authors:  Yesim Yilmaz-Demirdag
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

6.  Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center.

Authors:  Magda Carneiro-Sampaio; Dewton Moraes-Vasconcelos; Cristina M Kokron; Cristina M A Jacob; Myrthes Toledo-Barros; Mayra B Dorna; Letícia A Watanabe; Ana Karolina B B Marinho; Ana Paula Moschione Castro; Antonio C Pastorino; Clóvis Artur A Silva; Maurício D Ferreira; Luiz V Rizzo; Jorge E Kalil; Alberto J S Duarte
Journal:  J Clin Immunol       Date:  2013-01-29       Impact factor: 8.317

7.  Otitis media in children with congenital immunodeficiencies.

Authors:  Simon Urschel
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

8.  IgA deficiency: correlation between clinical and immunological phenotypes.

Authors:  Asghar Aghamohammadi; Taher Cheraghi; Mohammad Gharagozlou; Masoud Movahedi; Nima Rezaei; Mehdi Yeganeh; Nima Parvaneh; Hassan Abolhassani; Zahra Pourpak; Mostafa Moin
Journal:  J Clin Immunol       Date:  2008-08-06       Impact factor: 8.317

Review 9.  Clinical immunology review series: an approach to the patient with recurrent infections in childhood.

Authors:  M A Slatter; A R Gennery
Journal:  Clin Exp Immunol       Date:  2008-03-28       Impact factor: 4.330

10.  The Challenge of Immunoglobulin-G Subclass Deficiency and Specific Polysaccharide Antibody Deficiency--a Dutch Pediatric Cohort Study.

Authors:  Ellen J H Schatorjé; Everieke de Jong; Roeland W N M van Hout; Yumely García Vivas; Esther de Vries
Journal:  J Clin Immunol       Date:  2016-02-04       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.